Citigroup’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-10,000
Closed -$254K 5951
2022
Q3
$254K Hold
10,000
﹤0.01% 3658
2022
Q2
$332K Sell
10,000
-258,000
-96% -$11M ﹤0.01% 3538
2022
Q1
$19.3M Sell
268,000
-257,900
-49% -$18.6M 0.01% 964
2021
Q4
$48.3M Buy
525,900
+447,900
+574% +$53.5M 0.03% 573
2021
Q3
$9.89M Buy
78,000
+28,000
+56% +$4.08M 0.01% 1421
2021
Q2
$8.31M Sell
50,000
-61,500
-55% -$9.96M 0.01% 1541
2021
Q1
$20.3M Buy
111,500
+32,618
+41% +$7.57M 0.01% 944
2020
Q4
$15.8M Buy
78,882
+38,982
+98% +$7.93M 0.01% 1204
2020
Q3
$8.75M Buy
39,900
+400
+1% +$84.7K 0.01% 1476
2020
Q2
$7.54M Sell
39,500
-10,800
-21% -$1.89M 0.01% 1533
2020
Q1
$7.8M Buy
50,300
+13,500
+37% +$1.57M 0.01% 1327
2019
Q4
$3.08M Buy
36,800
+1,900
+5% +$145K ﹤0.01% 2505
2019
Q3
$2.36M Buy
34,900
+7,100
+26% +$467K ﹤0.01% 2676
2019
Q2
$1.85M Buy
27,800
+18,500
+199% +$1.08M ﹤0.01% 2954
2019
Q1
$517K Sell
9,300
-2,000
-18% -$122K ﹤0.01% 4147
2018
Q4
$560K Buy
11,300
+2,900
+35% +$177K ﹤0.01% 4004
2018
Q3
$725K Buy
+8,400
New +$599K ﹤0.01% 3845

Other funds holding TDOC

Citigroup's TDOC Position: Q1 2026 in Review

Citigroup increased its Teladoc Health (TDOC) stake by 112% in Q1 2026, buying an estimated $95.8K and bringing the position to 32,364 shares worth $176K. The position accounts for ﹤0.01% of the portfolio, ranked #4056.

Citigroup first reported a position in TDOC in Q3 2015 and has held it in 42 quarters since. The position peaked at $115M in Q3 2021. 322 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.

  • Citigroup held 32,364 shares of Teladoc Health worth $176K as of Q1 2026.
  • Citigroup bought 17,082 Teladoc Health shares in Q1 2026, an estimated $95.8K.
  • Teladoc Health made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #4056 holding.
  • Citigroup first reported a position in Teladoc Health in Q3 2015 and has held it in 42 quarters since.
  • Citigroup's Teladoc Health position peaked at $115M in Q3 2021.
  • 322 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.